Your browser is no longer supported. Please, upgrade your browser.
VRTX Vertex Pharmaceuticals Incorporated monthly Stock Chart
VRTX [NASD]
Vertex Pharmaceuticals Incorporated
IndexS&P 500 P/E54.55 EPS (ttm)4.51 Insider Own0.20% Shs Outstand258.05M Perf Week0.48%
Market Cap63.46B Forward P/E24.24 EPS next Y10.15 Insider Trans-60.36% Shs Float254.83M Perf Month4.43%
Income1.18B PEG1.97 EPS next Q1.78 Inst Own96.70% Short Float1.23% Perf Quarter19.97%
Sales4.16B P/S15.24 EPS this Y118.10% Inst Trans-1.96% Short Ratio2.30 Perf Half Y32.98%
Book/sh23.58 P/B10.43 EPS next Y31.78% ROA16.00% Target Price266.60 Perf Year30.77%
Cash/sh14.76 P/C16.66 EPS next 5Y27.75% ROE22.30% 52W Range163.68 - 249.00 Perf YTD12.32%
Dividend- P/FCF42.48 EPS past 5Y28.00% ROI14.70% 52W High-1.23% Beta1.44
Dividend %- Quick Ratio3.50 Sales past 5Y48.30% Gross Margin86.80% 52W Low50.25% ATR6.08
Employees3000 Current Ratio3.60 Sales Q/Q62.40% Oper. Margin28.80% RSI (14)64.39 Volatility2.56% 2.54%
OptionableYes Debt/Eq0.09 EPS Q/Q-62.40% Profit Margin28.30% Rel Volume0.81 Prev Close243.82
ShortableYes LT Debt/Eq0.09 EarningsJan 30 AMC Payout0.00% Avg Volume1.36M Price245.93
Recom1.90 SMA204.09% SMA507.76% SMA20027.52% Volume1,305,401 Change0.87%
Jan-31-20Downgrade Robert W. Baird Outperform → Neutral $210 → $230
Nov-19-19Upgrade Guggenheim Neutral → Buy $252
Nov-12-19Initiated SunTrust Buy $235
Oct-17-19Resumed BofA/Merrill Buy $220
Sep-03-19Upgrade Goldman Neutral → Buy $226 → $254
Aug-01-19Downgrade Needham Buy → Hold
May-23-19Resumed Citigroup Buy $205
May-21-19Initiated Credit Suisse Outperform $209
Apr-12-19Initiated Evercore ISI In-line
Mar-26-19Upgrade William Blair Mkt Perform → Outperform
Mar-19-19Downgrade SVB Leerink Outperform → Mkt Perform
Feb-06-19Downgrade Maxim Group Buy → Hold
Jan-02-19Downgrade Raymond James Outperform → Mkt Perform
Oct-26-18Upgrade H.C. Wainwright Neutral → Buy $220
Oct-01-18Initiated Cantor Fitzgerald Overweight $217
Aug-07-18Reiterated Stifel Buy $182 → $200
Mar-05-18Reiterated Maxim Group Buy $195 → $200
Feb-13-18Reiterated JMP Securities Mkt Outperform $200 → $211
Feb-01-18Reiterated Barclays Overweight $180 → $200
Jan-05-18Upgrade BofA/Merrill Neutral → Buy
Feb-18-20 07:04AM  Vertex's Cystic Fibrosis Franchise and Healthy Pipeline Support a Narrow Moat Rating Morningstar
Feb-14-20 10:11AM  What's in Store for Vertex in 2020 After a Remarkable 2019? Zacks
09:02AM  Vertex Is the Top Big Biotech, According to Citi. 3 More Stocks It Says to Buy. Barrons.com
Feb-12-20 09:32AM  Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain Zacks
Feb-10-20 01:52PM  Edited Transcript of VRTX earnings conference call or presentation 30-Jan-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-06-20 04:43PM  How This IBD Stock Of The Day Clawed Its Way Above Two Buy Points Investor's Business Daily
07:24AM  Looking for another Apple or Amazon? These stocks have one important thing in common with techs big winners MarketWatch
Feb-05-20 12:45PM  3 Reasons Growth Investors Will Love Vertex (VRTX) Zacks
12:20PM  Why Vertex (VRTX) Might be Well Poised for a Surge Zacks
11:30AM  Is Vertex Pharmaceuticals (VRTX) Stock Outpacing Its Medical Peers This Year? Zacks
11:15AM  Biotech Stock Roundup: Earnings Updates From VRTX, AMGN, GILD; AIMT Gains FDA Nod Zacks
10:00AM  Biotech Stocks Ran Up In 2019 Who's Leading The Pack For 2020? Investor's Business Daily
09:15AM  Vertex (VRTX) Hits 52-Week High, Can the Run Continue? Zacks
09:15AM  NASDAQ Reaches New Closing High as Rebound Continues Zacks
Feb-04-20 07:40PM  Buy this Cloud-Based Business Services Stock After Earnings on Strong Growth? Zacks
02:32PM  Eaton Vance Exits Celgene, Trims Amgen Position GuruFocus.com
08:41AM  Earnings Beat: Vertex Pharmaceuticals Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St.
Jan-31-20 03:02PM  Vertex (VRTX) Q4 Earnings Beat on Solid CF Product Sales Zacks
12:16PM  Don't Underestimate Vertex Pharmaceuticals TheStreet.com
09:50AM  Dow Jones Falls On Coronavirus Fears; Amazon Leads 3 Stocks Flashing Buy Signals Investor's Business Daily
09:09AM  The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO Benzinga
09:08AM  Vertexs Cystic Fibrosis Therapy Looks Like a Hit. Early Sales Shocked the Street. Barrons.com
05:04AM  Dow Jones Futures Fall: Amazon Surges On Earnings, Leads Four Stocks Flashing Buy Signals Investor's Business Daily
05:00AM  Families of rare-disease patients take on drug development, but face uphill battle American City Business Journals
Jan-30-20 05:15PM  Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Top Estimates Zacks
05:11PM  Top Biotech Vertex Pops After Crushing Fourth-Quarter Expectations Investor's Business Daily
04:27PM  Vertex Pharma stock rises on earnings, outlook beat MarketWatch
04:01PM  Vertex Reports Full-Year and Fourth-Quarter 2019 Financial Results Business Wire
11:06AM  Vertex Earnings, Revenue Beat in Q4 Investing.com
Jan-29-20 08:56AM  Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More Zacks
08:31AM  Why Vertex (VRTX) Might Surprise This Earnings Season Zacks
Jan-28-20 10:35AM  Can CF Drugs Drive Growth for Vertex (VRTX) in Q4 Earnings? Zacks
05:26AM  Acceleron stock soars on lung drug trial data American City Business Journals
Jan-23-20 05:50PM  Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know Zacks
12:31PM  Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: Should You Buy? Zacks
12:10PM  Why Vertex (VRTX) is Poised to Beat Earnings Estimates Again Zacks
11:13AM  If You Had Bought Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Three Years Ago, You Could Pocket A 175% Gain Today Simply Wall St.
Jan-22-20 01:01AM  Rally Pauses as Coronavirus Spreads to U.S. Zacks
Jan-21-20 04:30PM  Why This Top-Notch Biotech Stock Just Plunged By Double Digits Investor's Business Daily
04:01PM  Vertex to Announce Full-Year and Fourth-Quarter 2019 Financial Results on January 30 Business Wire
02:50PM  Mass. employers earn high marks in LGBTQ-friendly workplace index American City Business Journals
Jan-14-20 03:56PM  These 3 Momentum Stocks Have Room for Further Upside, Says Jefferies TipRanks
Jan-13-20 05:50PM  Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know Zacks
09:25AM  Vertex Tests Buy Point Investor's Business Daily Video
Jan-11-20 08:00AM  These Four Stocks Are In Buy Range Before Key Healthcare Conference Investor's Business Daily
Jan-10-20 02:20PM  Cambridge startup raises $110M for re-doseable gene therapies American City Business Journals
08:52AM  A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations Benzinga
Jan-09-20 08:13PM  As Tesla Stock Dances To New Highs, This Could Be The Next Proper Buy Point Investor's Business Daily
09:31AM  Thinking about trading options or stock in Electronic Arts, Tesla, UnitedHealth Group, Vertex Pharmaceuticals, or Workday? PR Newswire
08:08AM  Dow Jones Futures: Stock Market Rally Refuses To 'Stand Down'; Netflix, Vertex, Lululemon Clear Buy Points Investor's Business Daily
Jan-08-20 04:46PM  This IBD Stock Of The Day Is A Rarity Among Biotechs And It's Breaking Out Investor's Business Daily
04:01PM  Vertex to Present at the J.P. Morgan Healthcare Conference on January 13 Business Wire
08:57AM  Vertex Pharmaceuticals Stock Is Undervalued, Analyst Says Barrons.com
Jan-07-20 05:45PM  Vertex Pharmaceuticals (VRTX) Stock Moves -0.11%: What You Should Know Zacks
05:00AM  Top Picks 2020- Vertex Pharmaceuticals VRTX MoneyShow
Jan-06-20 03:11PM  These Are The 5 Best Stocks To Buy And Watch Now Investor's Business Daily
07:17AM  10 Stocks With the Highest Sales Growth in 2020 According to Goldman Investopedia
Dec-31-19 05:50PM  Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know Zacks
09:58AM  Dow Jones Today, Stocks Mixed As Trump Sets China Trade Deal Date, 3 Blue Chips In Buy Range Investor's Business Daily
08:25AM  The Zacks Analyst Blog Highlights: Medtronic, United Technologies, Union Pacific, Vertex Pharmaceuticals and NextEra Energy Zacks
Dec-30-19 02:34PM  Top Research Reports for Medtronic, United Technologies & Union Pacific Zacks
Dec-29-19 09:40PM  Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus Benzinga
Dec-27-19 09:39AM  The top-read BBJ stories of 2019 American City Business Journals
09:30AM  Vertex Shows Flat Action Investor's Business Daily Video
Dec-25-19 06:15PM  Vertex Pharmaceuticals Incorporated (VRTX) vs. Hedge Fund Favorites in 2019 Insider Monkey
Dec-24-19 12:38PM  Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) A High Quality Stock To Own? Simply Wall St.
12:15PM  Biotech Leading in Q4: Best ETFs & Stocks Zacks
07:30AM  10 Biotech M&A Targets Under The Scanner For 2020 Benzinga
Dec-23-19 05:50PM  Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know Zacks
Dec-20-19 11:30AM  Is Vertex Pharmaceuticals (VRTX) Stock Outpacing Its Medical Peers This Year? Zacks
08:13AM  New Strong Buy Stocks for December 20th Zacks
Dec-19-19 05:45PM  3 Tech Stocks for Growth Investors to Buy for 2020 Zacks
10:18AM  Biotech Stock Outlook: M&A Activity Retains Growth Streak Zacks
07:05AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Dec-17-19 05:45PM  Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know Zacks
Dec-16-19 07:05AM  New Strong Buy Stocks for December 16th Zacks
Dec-13-19 01:55PM  Vertex and Republic of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement to Include Triple Combination Therapy for All Eligible Patients Ages 12 and Over Once Licensed Business Wire
Dec-12-19 02:37PM  Stocks Hit Records on China Trade Hope & Buy this Biotech Stock - Free Lunch Zacks
10:53AM  New Strong Buy Stocks for December 12th Zacks
Dec-11-19 02:42PM  Vertex's Kalydeco Gets EU Approval to Treat CF in Infants Zacks
12:45PM  Looking for a Growth Stock? 3 Reasons Why Vertex (VRTX) is a Solid Choice Zacks
09:41AM  Biotech Stock Roundup: ASH Data in Focus, Amgen Gets FDA Nod to Remicade Biosimilar Zacks
07:24AM  The Zacks Analyst Blog Highlights: Spark Energy, Vertex, ResMed, Prologis and Boston Beer Zacks
Dec-10-19 08:09AM  5 Defensive Stocks to Buy as Volatility Index Soars Zacks
06:57AM  Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) in Infants With Cystic Fibrosis Ages 6 Months to Less Than 12 Months With Certain Mutations in the CFTR Gene Business Wire
Dec-09-19 09:55AM  Blueprint's (BPMC) Systemic Mastocytosis Study Data Impresses Zacks
09:52AM  Gilead (GILD) Announces Positive Long-Term Data on Yescarta Zacks
Dec-06-19 07:00AM  Three Stocks from the Zacks #1 Rank Uptrends Screen Zacks
Dec-05-19 03:53PM  Spero Posts Preliminary Data on SPR720 for Pulmonary Disease Zacks
03:49AM  Gene Therapy the Next Best Thing: Here's Why (Revised) Zacks
Dec-04-19 10:25AM  Biogen's Lupus Candidate Meets Endpoint in Phase II Study Zacks
09:42AM  Gene Therapy the Next Best Thing: Here's Why Zacks
Dec-03-19 10:45AM  Seattle Genetics, Astellas Tie Up With Merck for Cancer Study Zacks
08:59AM  Puma Biotech Expands Pierre Fabre License to Add Countries Zacks
Dec-02-19 11:00AM  Looking For Growth? Take A Look At These Biotechnology Stocks Investor's Business Daily
10:22AM  Acorda (ACOR) Down More Than 80% Year to Date: Here's Why Zacks
09:09AM  In the money Dec. 2: $49M reported raised American City Business Journals
Nov-29-19 12:15PM  Biotech Tops in November: Best ETFs & Stocks Zacks
Nov-28-19 07:02PM  Hedge Funds Are Warming Up To Vertex Pharmaceuticals Incorporated (VRTX) Insider Monkey
08:10AM  Incyte's NDA for Pemigatinib Gets FDA's Priority Review Tag Zacks
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene. It is also developing VX-659 and VX-445 that are Phase III clinical trials; VX-121, a cystic fibrosis transmembrane conductance regulator corrector that is in Phase I/II clinical trial; VX-150, an inhibitor that is in Phase IIb clinical trial for acute pain; CTX001 that is in Phase I/II clinical trial for the treatment of beta-thalassemia and sickle cell diseases; and a novel drug candidate, which is in Phase I clinical trial for the treatment for alpha-1 antitrypsin deficiency. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG; Arbor Biotechnologies, Inc.; Moderna Therapeutics, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany; X-Chem, Inc.; Janssen Pharmaceuticals, Inc.; Merck KGaA; Kymera Therapeutics; Ribometrix, Inc.; and Molecular Templates, Inc. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALTSHULER DAVIDEVP, Global Research and CSOFeb 11Sale246.1117,0324,191,77139,970Feb 12 05:11 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 11Sale246.0911,2862,777,32547,335Feb 12 05:13 PM
LEIDEN JEFFREY MCEO & PresidentFeb 11Sale246.0947,52311,694,933132,540Feb 12 05:19 PM
Parini MichaelEVP, CL&AOFeb 11Sale246.1116,8824,154,83237,906Feb 12 05:20 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 11Sale246.0813,0703,216,31146,198Feb 12 05:22 PM
Silva Paul MSVP & ControllerFeb 11Sale246.045,8621,442,30119,688Feb 12 05:24 PM
Lee YuchunDirectorFeb 10Option Exercise57.271,18167,6363,056Feb 12 05:14 PM
Lee YuchunDirectorFeb 10Sale242.511,181286,4031,875Feb 12 05:14 PM
Lee YuchunDirectorFeb 07Option Exercise57.272,000114,5403,875Feb 11 04:17 PM
Lee YuchunDirectorFeb 07Sale237.822,000475,6431,875Feb 11 04:17 PM
Silva Paul MSVP & ControllerFeb 06Option Exercise187.5346687,38930,689Feb 07 04:27 PM
Tatsis OuraniaSVP, CROFeb 06Option Exercise174.05967168,30217,913Feb 07 04:28 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 06Option Exercise173.512,787483,55970,350Feb 07 04:08 PM
Parini MichaelEVP, CL&AOFeb 06Option Exercise172.062,526434,61470,772Feb 07 04:17 PM
Lee YuchunDirectorFeb 06Option Exercise57.272,000114,5403,875Feb 10 04:14 PM
Silva Paul MSVP & ControllerFeb 06Sale239.32466111,52330,223Feb 07 04:27 PM
Tatsis OuraniaSVP, CROFeb 06Sale239.43967231,52716,946Feb 07 04:28 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 06Sale239.422,526604,77570,310Feb 07 04:07 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 06Sale239.422,787667,25367,563Feb 07 04:08 PM
Kewalramani ReshmaEVP and CMOFeb 06Sale239.442,074496,60035,285Feb 07 04:14 PM
Parini MichaelEVP, CL&AOFeb 06Sale239.422,526604,78368,246Feb 07 04:17 PM
Lee YuchunDirectorFeb 06Sale239.512,000479,0171,875Feb 10 04:14 PM
Lee YuchunDirectorFeb 05Option Exercise57.272,000114,5403,875Feb 06 04:06 PM
Lee YuchunDirectorFeb 05Sale242.382,000484,7631,875Feb 06 04:06 PM
Lee YuchunDirectorFeb 04Option Exercise57.273,028173,4143,875Feb 06 04:06 PM
Lee YuchunDirectorFeb 04Sale238.842,000477,6721,875Feb 06 04:06 PM
Parini MichaelEVP, CL&AOFeb 03Option Exercise86.522,330201,59235,989Feb 04 04:13 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 03Option Exercise88.494,126365,11735,679Feb 05 04:50 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 03Option Exercise88.904,097364,23940,287Feb 05 04:51 PM
Silva Paul MSVP & ControllerFeb 03Option Exercise89.302,099187,44919,858Feb 05 04:52 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 03Sale231.123,710857,46533,240Feb 04 04:10 PM
Lee YuchunDirectorFeb 03Sale231.102,000462,196847Feb 04 04:11 PM
Parini MichaelEVP, CL&AOFeb 03Sale231.144,4361,025,35031,553Feb 04 04:13 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 03Sale231.184,126953,86131,553Feb 05 04:50 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 03Sale231.114,097946,84536,190Feb 05 04:51 PM
Silva Paul MSVP & ControllerFeb 03Sale231.032,099484,93917,759Feb 05 04:52 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJan 31Option Exercise187.534,692879,89137,932Feb 04 04:10 PM
Parini MichaelEVP, CL&AOJan 31Option Exercise187.533,909733,05538,912Feb 04 04:13 PM
SACHS BRUCE IDirectorJan 31Option Exercise53.8520,0001,077,00031,210Feb 04 04:15 PM
Silva Paul MSVP & ControllerJan 31Option Exercise187.531,396261,79219,155Feb 04 04:17 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJan 31Sale238.654,6921,119,74633,240Feb 04 04:10 PM
Lee YuchunDirectorJan 31Sale228.022,000456,0422,847Feb 04 04:11 PM
Parini MichaelEVP, CL&AOJan 31Sale238.653,909932,88335,003Feb 04 04:13 PM
SACHS BRUCE IDirectorJan 31Sale227.9920,0004,559,83011,210Feb 04 04:15 PM
Silva Paul MSVP & ControllerJan 31Sale238.651,396333,15517,759Feb 04 04:17 PM
Parini MichaelEVP, CL&AOJan 22Option Exercise187.53118835,004Jan 24 04:10 PM
Parini MichaelEVP, CL&AOJan 22Sale237.50123835,003Jan 24 04:10 PM
Sachdev AmitEVP, Chief Patient OfficerJan 16Option Exercise109.145,000545,70041,190Jan 21 04:14 PM
Sachdev AmitEVP, Chief Patient OfficerJan 16Sale235.005,0001,175,00036,190Jan 21 04:14 PM
Parini MichaelEVP, CL&AOJan 13Option Exercise90.292,125191,86637,128Jan 15 04:08 PM
Silva Paul MSVP & ControllerJan 13Option Exercise90.2986077,64918,619Jan 15 04:09 PM
Parini MichaelEVP, CL&AOJan 13Sale226.782,125481,91135,003Jan 15 04:08 PM
Silva Paul MSVP & ControllerJan 13Sale229.38860197,26717,759Jan 15 04:09 PM
Sachdev AmitEVP, Chief Patient OfficerJan 08Option Exercise109.145,000545,70041,190Jan 10 04:46 PM
Tatsis OuraniaSVP, CROJan 08Option Exercise187.531,675314,1138,927Jan 10 04:22 PM
Silva Paul MSVP & ControllerJan 08Option Exercise131.8913,7501,813,48831,509Jan 10 04:32 PM
Sachdev AmitEVP, Chief Patient OfficerJan 08Sale230.005,0001,150,00036,190Jan 10 04:46 PM
Tatsis OuraniaSVP, CROJan 08Sale227.531,675381,1137,252Jan 10 04:22 PM
Silva Paul MSVP & ControllerJan 08Sale231.8913,7503,188,48817,759Jan 10 04:32 PM
Parini MichaelEVP, CL&AOJan 06Option Exercise122.454,250520,41339,253Jan 08 04:11 PM
Parini MichaelEVP, CL&AOJan 06Sale222.004,250943,51435,003Jan 08 04:11 PM
Silva Paul MSVP & ControllerJan 02Option Exercise102.3725,6302,623,81043,389Jan 06 04:17 PM
YOUNG WILLIAM DDirectorJan 02Option Exercise72.1420,0001,442,80029,311Jan 06 04:18 PM
Silva Paul MSVP & ControllerJan 02Sale218.9225,6305,610,99317,759Jan 06 04:17 PM
YOUNG WILLIAM DDirectorJan 02Sale218.9320,0004,378,6969,311Jan 06 04:18 PM
YOUNG WILLIAM DDirectorDec 30Option Exercise65.6530,0001,969,50039,311Jan 02 04:21 PM
YOUNG WILLIAM DDirectorDec 30Sale218.7630,0006,562,7159,311Jan 02 04:21 PM
Sachdev AmitEVP, Chief Patient OfficerDec 09Option Exercise109.145,000545,70038,416Dec 10 04:49 PM
Sachdev AmitEVP, Chief Patient OfficerDec 09Sale225.005,0001,125,00033,416Dec 10 04:49 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 25Option Exercise187.533,910733,24235,463Nov 26 04:11 PM
Kewalramani ReshmaEVP and CMONov 25Option Exercise187.534,692879,89117,790Nov 26 04:12 PM
Sachdev AmitEVP, Chief Patient OfficerNov 25Option Exercise109.145,000545,70038,416Nov 26 04:13 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 25Sale219.373,910857,73731,553Nov 26 04:11 PM
Kewalramani ReshmaEVP and CMONov 25Sale219.374,6921,029,28413,098Nov 26 04:12 PM
Sachdev AmitEVP, Chief Patient OfficerNov 25Sale220.005,0001,100,00033,416Nov 26 04:13 PM
Sachdev AmitEVP, Chief Patient OfficerNov 19Option Exercise109.145,000545,70038,416Nov 21 04:19 PM
LEIDEN JEFFREY MCEO & PresidentNov 19Option Exercise116.8096,53411,275,141202,880Nov 21 04:21 PM
Sachdev AmitEVP, Chief Patient OfficerNov 19Sale215.005,0001,075,00033,416Nov 21 04:19 PM
LEIDEN JEFFREY MCEO & PresidentNov 19Sale210.9196,53420,360,052106,346Nov 21 04:21 PM
LEIDEN JEFFREY MCEO & PresidentNov 18Option Exercise116.804,434517,893109,287Nov 19 04:12 PM
LEIDEN JEFFREY MCEO & PresidentNov 18Sale210.004,434931,140106,346Nov 19 04:12 PM
LEIDEN JEFFREY MCEO & PresidentNov 15Option Exercise116.805,000583,988109,663Nov 19 04:12 PM
Tatsis OuraniaSVP, CRONov 15Sale205.9551,0307,252Nov 19 04:17 PM
Sachdev AmitEVP, Chief Patient OfficerNov 15Sale205.955711,73933,416Nov 19 04:16 PM
Parini MichaelEVP, CL&AONov 15Sale205.958417,30035,003Nov 19 04:15 PM
LEIDEN JEFFREY MCEO & PresidentNov 15Sale210.005,0001,050,000106,346Nov 19 04:12 PM
Kewalramani ReshmaEVP and CMONov 15Sale205.956112,56313,098Nov 19 04:11 PM
Arbuckle Stuart AEVP\Chief Commercial OfficerNov 15Sale205.95193,91333,240Nov 19 04:09 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 15Sale205.956012,35731,553Nov 19 04:07 PM
Arbuckle Stuart AEVP\Chief Commercial OfficerNov 13Option Exercise155.578,5601,331,67941,800Nov 15 04:03 PM
Parini MichaelEVP, CL&AONov 13Option Exercise155.574,892761,04839,895Nov 15 04:05 PM
Tatsis OuraniaSVP, CRONov 13Option Exercise155.572,853443,84110,105Nov 15 04:07 PM
Tatsis OuraniaSVP, CRONov 13Sale205.592,853586,5487,252Nov 15 04:07 PM
Parini MichaelEVP, CL&AONov 13Sale205.504,8921,005,30635,003Nov 15 04:05 PM
Arbuckle Stuart AEVP\Chief Commercial OfficerNov 13Sale205.578,5601,759,67933,240Nov 15 04:03 PM
Kewalramani ReshmaEVP and CMONov 08Option Exercise155.5750979,18513,607Nov 13 04:08 PM
Kewalramani ReshmaEVP and CMONov 08Sale199.00509101,29113,098Nov 13 04:08 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 06Option Exercise155.571,223190,26232,776Nov 07 04:36 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 06Sale197.211,223241,18931,553Nov 07 04:36 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 04Option Exercise88.494,126365,11735,679Nov 06 04:10 PM